Navigation Links
MEDRAD Installs First Intego(TM) PET Infusion System
Date:8/7/2008

WARRENDALE, Pa., Aug. 7 /PRNewswire/ -- MEDRAD, INC., announced today the first installation of its Intego(TM) PET Infusion System at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center. To achieve this milestone, MEDRAD has partnered with IBA Molecular which will supply UPMC with Fluorodeoxyglucose (FDG) in a multi-dose vial housed in a specially-designed Tungsten vial shield. Use of this innovative system minimizes the need to manually prepare and handle individual FDG doses, significantly reducing potential radiation exposure to hospital personnel.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

The Intego System automates the administration of FDG for Positron Emission Tomography/Computed Tomography (PET/CT) imaging procedures. By automating and controlling FDG dosing and infusion, the Intego System precisely, flexibly, safely, and easily administers FDG to patients throughout the day.

The Intego System automatically extracts a patient dose from a multi-dose vial and administers the dose, via infusion, directly to the patient, minimizing the need for manual dose preparation and associated handling, as well as protecting the technologist from the corresponding radiation exposure. With the Intego System's dose-on-demand capability, the prescribed dose may be administered when the patient and technologist are ready, enabling technologists to easily and efficiently respond to schedule changes, patient delays, and add-on patients.

"MEDRAD will improve the quality of healthcare for patients and will enhance procedure safety for clinicians at Intego's first clinical site, UPMC, Hillman Cancer Center. The partnership with IBA Molecular helps us achieve this part of our mission," said Doug Descalzi, executive director, MEDRAD Molecular Imaging.

"IBA is very pleased to support this first clinical installation
'/>"/>

SOURCE MEDRAD, INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
2. Bayer HealthCare Affiliate MEDRAD Successfully Completes Tender Offer for Shares of Possis Medical; Announces Subsequent Offering Period
3. MEDRAD, Battelle Win Medical Design Excellence Award for MEDRAD XDS(TM) Extravasation Detector
4. MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award
5. MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
6. Tasker Products Installs Scalder Application at New Poultry Processors Facility
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
9. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
10. Genmab Announces 2007 First Half Year Results
11. Pharsight Achieves First License Sale for Public-Source Database
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 Junto Health, a company that ... and develop new technology solutions, today announced the launch ... a leader in health care policy consulting. Working together ... a collaborative innovation process while, at the same time, ... public policy, health care finance and the delivery of ...
(Date:7/26/2015)... , ... July 26, 2015 , ... ... its VALIDATE® ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA kit ... VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal delta” method for ...
(Date:7/24/2015)... ... 24, 2015 , ... VetStem Biopharma, proudly announces a new long term partnership ... training and clinical opportunities. , “We are very excited to be able to partner ... area. Stem cell therapy is an established treatment for arthritic conditions in our pets ...
(Date:7/24/2015)... SAN DIEGO , July 24, 2015 ... corporate and financial results for the second quarter 2015 ... the announcement, Orexigen will provide a business update and ... conference call at 8:00 a.m. Eastern Time (5:00 a.m. ... accessed by phone by calling (800) 447-0521 (domestic) or ...
Breaking Biology Technology:Junto Health Announces a Unique Partnership with Sachs Policy Group 2Junto Health Announces a Unique Partnership with Sachs Policy Group 3Junto Health Announces a Unique Partnership with Sachs Policy Group 4Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 2VetStem Biopharma, proudly announces a new long term partnership with VCA Emergency Animal Hospital & Referral Center. 3
... Mass., Oct. 5 Verenium Corporation (Nasdaq: VRNMD ... ethanol and high-performance specialty enzymes, today announced that it ... conditions, shares of its common stock, and potentially warrants, ... expected to price before 9:30 am EDT on Tuesday, ...
... ... (NEIRP) has announced it is a sponsor for this year’s 4th Annual Orthopedic Design ... October 6-8, 2009. NEIRP partners and staff will also be available to meet ... the benefits the region has to offer to the medical device industry . ...
... Oct. 5 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that ... Wright and Dr. Valerie Riddle, Vice President and ... Television Channel (HSTV) 30-minute documentary training video entitled, ...
Cached Biology Technology:Verenium Announces Proposed Public Offering of Common Stock 2Verenium Announces Proposed Public Offering of Common Stock 3Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 2Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition 3PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 2PharmAthene Executives Featured in Anthrax Pathogen Training Video for U.S. Department of Homeland Security 3
(Date:7/23/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) has ... of the Biometrics Industry 2015 " report ... biometrics market is likely to witness significant growth ... the uptake of multiple technologies available. The year ... growth of biometrics in existing applications as well ...
(Date:7/21/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market and creator ... has filed provisional patent 62/192218 for ... This invention highlights next generation payment technology from ... also the user using unique personal identifiers including ...
(Date:7/20/2015)... 20, 2015  Acuity Market Intelligence,s latest research ... of Commerce and Privacy" forecasts that between 2014 ... will be downloaded to smart mobile devices by ... market is projected to generate more than $67.9 ... seven-year forecast period.    "Biometrics is ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... center called the National Resource for Network Biology (NRNB), ... of Medicine, will help clinicians analyze an ever-growing wealth ... real problems and diseases. In recent years, ... shifting much of their focus from single cells to ...
... PORTLAND, Ore. Oregon Health & Science University Doernbecher ... landmark clinical trial to further assess the safety and ... as a potential treatment for infantile or late-infantile neuronal ... disorder that affects infants and children. The Phase ...
... 28 October 2010 (Geneva, Switzerland) - A report issued ... Here, Right Now documents the principal debates around ... The report also takes stock of progress to date and ... and prevention at a time when new infections are outstripping ...
Cached Biology News:New center looks at how human systems function or fail 2New center looks at how human systems function or fail 3OHSU Doernbecher Children's Hospital conducts second phase of landmark Batten study 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 2New report underlines the threat to universal access to HIV prevention, treatment and care due to a slow-down in treatment scale-up and waning political will 3
... Mouse monoclonal antibody raised ... Immunogen: ... 206 a.a) partial recombinant protein ... Accession Number: NM_005802 ...
Mouse monoclonal antibody raised against a partial recombinant PASK. NCBI Entrez Gene ID = PASK...
Agarose II (Low Melt)...
...
Biology Products: